\-\ Texto\\:\\ \ \(0\)\
\-\ due\\ to\\ an\\ interval\\ increase\\ in\\ size\\ of\\ the\\ mass\\ from\\ 4\\.5\\ x\\ 4\\.1\\ cm\\ to\\ 5\\.3\\ x\\ 4\\.2\\ cm\\,\\ and\\ the\\ increased\\ risk\\ of\\ hemorrage\\,\\ treatment\\ was\\ indicated\\.\\ \\ the\\ patient\\ underwent\\ selective\\ catheter\\ based\\ embolization\\,\\ as\\ embolization\\ is\\ an\\ effective\\,\\ minimally\\ invasive\\ treatment\\.\\ \\ the\\ technical\\ success\\ rate\\ is\\ near\\ 100\\%\\,\\ with\\ a\\ rare\\ incidence\\ of\\ recurrence\\ in\\ sporadic\\ amls\\.\ \(0\)\
\-\ kothary\\ n\\,\\ soulen\\ mc\\,\\ clark\\ tw\\,\\ et\\ al\\.\\ renal\\ angiomyolipoma\\:\\ long\\-term\\ results\\ after\\ arterial\\ embolization\\.\\ j\\ vasc\\ interv\\ radiol\\.\\ 2005\\;\\ 16\\:45\\-50\\.\ \(0\)\
\-\ contrast\\ enhanced\\ axial\\ ct\\ images\\ reveal\\ a\\ large\\ enhancing\\ mass\\ involving\\ the\\ upper\\ pole\\ of\\ the\\ right\\ kidney\\.\\ \\ the\\ mass\\ has\\ multiple\\ foci\\ of\\ fat\\ density\\.\ \(0\)\
\-\ catheter\\ angiogram\\ demonstrates\\ a\\ single\\ right\\ renal\\ artery\\,\\ with\\ a\\ defect\\ in\\ the\\ upper\\ pole\\ corresponding\\ to\\ the\\ angiomyolipoma\\.\\ \\ there\\ is\\ minimal\\ blood\\ supply\\ to\\ this\\ lesion\\ although\\ it\\ arises\\ from\\ a\\&\\#8232\\;\\ single\\ upper\\ pole\\ branch\\.\\ the\\ artery\\ supplying\\ this\\ mass\\ was\\ subselected\\ with\\ a\\ microcatheter\\ and\\ \\&\\#8232\\;then\\ embolized\\ to\\ obtain\\ arterial\\ stasis\\ using\\ 300\\ to\\ 500\\ micron\\&\\#8232\\;\\ bead\\ block\\.\\ \\ \ \(0\)\
\-\ post\\-embolization\\ image\\ shows\\ absent\\ flow\\ to\\ the\\ mass\\.\ \(0\)\
\-\ renal\\ angiomyolipoma\ \(9\)\
\-\ \\â\\€\\¢\\ angiomyolipoma\ \(2\)\
\-\ \\â\\€\\¢\\ renal\\ cell\\ carcinoma\ \(1\)\
\-\ 76\\ y\\.o\\.\\ woman\\ with\\ right\\ flank\\ pain\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 8232\\:\\ 0\\.3260322072282346\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.3232470430215227\ \(0\)\
\-\ embolization\\:\\ 0\\.2633548295422635\ \(0\)\
\-\ pole\\:\\ 0\\.19751612215669762\ \(0\)\
\-\ renal\\:\\ 0\\.18817477510465044\ \(0\)\
\-\ the\\:\\ 0\\.16581251209457057\ \(0\)\
\-\ mass\\:\\ 0\\.14427990831832307\ \(0\)\
\-\ catheter\\:\\ 0\\.13430633754115345\ \(0\)\
\-\ to\\:\\ 0\\.1322018332373408\ \(0\)\
\-\ arterial\\:\\ 0\\.12442521548285974\ \(0\)\
\-\ upper\\:\\ 0\\.1211094297695915\ \(0\)\
\-\ micron\\:\\ 0\\.12081209882764951\ \(0\)\
\-\ single\\:\\ 0\\.11617857576137308\ \(0\)\
\-\ kothary\\:\\ 0\\.11544241012085994\ \(0\)\
\-\ soulen\\:\\ 0\\.11544241012085994\ \(0\)\
\-\ clark\\:\\ 0\\.11544241012085994\ \(0\)\
\-\ interv\\:\\ 0\\.11544241012085994\ \(0\)\
\-\ vasc\\:\\ 0\\.11163255535235032\ \(0\)\
\-\ subselected\\:\\ 0\\.11163255535235032\ \(0\)\
\-\ bead\\:\\ 0\\.11163255535235032\ \(0\)\
\-\ tw\\:\\ 0\\.10867740240941154\ \(0\)\
\-\ hemorrage\\:\\ 0\\.10626286664556074\ \(0\)\
\-\ amls\\:\\ 0\\.10626286664556074\ \(0\)\
\-\ microcatheter\\:\\ 0\\.10422140574532576\ \(0\)\
\-\ technical\\:\\ 0\\.09504186227002656\ \(0\)\
\-\ supplying\\:\\ 0\\.09504186227002656\ \(0\)\
\-\ artery\\:\\ 0\\.09383632819678785\ \(0\)\
\-\ radiol\\:\\ 0\\.09171363446347194\ \(0\)\
\-\ selective\\:\\ 0\\.08967217356323696\ \(0\)\
\-\ stasis\\:\\ 0\\.08905609588454379\ \(0\)\
\-\ embolized\\:\\ 0\\.08736316251587437\ \(0\)\
\-\ cm\\:\\ 0\\.0867721246281448\ \(0\)\
\-\ 300\\:\\ 0\\.08634394575668236\ \(0\)\
\-\ sporadic\\:\\ 0\\.08586231879472736\ \(0\)\
\-\ 500\\:\\ 0\\.08586231879472736\ \(0\)\
\-\ obtain\\:\\ 0\\.08451438188658554\ \(0\)\
\-\ block\\:\\ 0\\.08451438188658554\ \(0\)\
\-\ success\\:\\ 0\\.08181806353807451\ \(0\)\
\-\ arises\\:\\ 0\\.08081176075538067\ \(0\)\
\-\ mc\\:\\ 0\\.07928786518881471\ \(0\)\
\-\ effective\\:\\ 0\\.07716440228138317\ \(0\)\
\-\ supply\\:\\ 0\\.07599166468166507\ \(0\)\
\-\ right\\:\\ 0\\.07513838068546502\ \(0\)\
\-\ 76\\:\\ 0\\.0743077128540991\ \(0\)\
\-\ branch\\:\\ 0\\.07411151249742286\ \(0\)\
\-\ of\\:\\ 0\\.07391861968324047\ \(0\)\
\-\ treatment\\:\\ 0\\.07197170609580174\ \(0\)\
\-\ 2005\\:\\ 0\\.07179471357459358\ \(0\)\
\-\ minimally\\:\\ 0\\.07163221728008147\ \(0\)\
\-\ corresponding\\:\\ 0\\.0706970089339454\ \(0\)\
\-\ invasive\\:\\ 0\\.06874182379063327\ \(0\)\
\-\ interval\\:\\ 0\\.06835793366969979\ \(0\)\
\-\ angiogram\\:\\ 0\\.06786280004482038\ \(0\)\
\-\ flank\\:\\ 0\\.06626252857329187\ \(0\)\
\-\ incidence\\:\\ 0\\.06502970586314519\ \(0\)\
\-\ reveal\\:\\ 0\\.06354639130650241\ \(0\)\
\-\ recurrence\\:\\ 0\\.062372167284217024\ \(0\)\
\-\ indicated\\:\\ 0\\.06213354313733938\ \(0\)\
\-\ using\\:\\ 0\\.06213354313733938\ \(0\)\
\-\ is\\:\\ 0\\.062065122307785145\ \(0\)\
\-\ 100\\:\\ 0\\.06197681607918488\ \(0\)\
\-\ absent\\:\\ 0\\.06197681607918488\ \(0\)\
\-\ foci\\:\\ 0\\.0617451492646708\ \(0\)\
\-\ near\\:\\ 0\\.0615174654586462\ \(0\)\
\-\ increase\\:\\ 0\\.06064396550096322\ \(0\)\
\-\ al\\:\\ 0\\.06002468625526558\ \(0\)\
\-\ from\\:\\ 0\\.06000614392193075\ \(0\)\
\-\ et\\:\\ 0\\.059178390194400604\ \(0\)\
\-\ with\\:\\ 0\\.0591702288327099\ \(0\)\
\-\ results\\:\\ 0\\.0588667691851399\ \(0\)\
\-\ an\\:\\ 0\\.057775925115714964\ \(0\)\
\-\ minimal\\:\\ 0\\.05763257773106667\ \(0\)\
\-\ enhanced\\:\\ 0\\.057520819415099095\ \(0\)\
\-\ rate\\:\\ 0\\.05724548139250479\ \(0\)\
\-\ rare\\:\\ 0\\.05702925974297366\ \(0\)\
\-\ in\\:\\ 0\\.05637905832340543\ \(0\)\
\-\ defect\\:\\ 0\\.05541591752240795\ \(0\)\
\-\ based\\:\\ 0\\.05472239353031481\ \(0\)\
\-\ risk\\:\\ 0\\.053977947009548055\ \(0\)\
\-\ then\\:\\ 0\\.05347656415844626\ \(0\)\
\-\ kidney\\:\\ 0\\.05307277428643649\ \(0\)\
\-\ involving\\:\\ 0\\.05291464366918476\ \(0\)\
\-\ was\\:\\ 0\\.05265601114920997\ \(0\)\
\-\ underwent\\:\\ 0\\.05204030761933638\ \(0\)\
\-\ this\\:\\ 0\\.051916900104905454\ \(0\)\
\-\ although\\:\\ 0\\.05142924728559787\ \(0\)\
\-\ size\\:\\ 0\\.05115116290868284\ \(0\)\
\-\ flow\\:\\ 0\\.05031797738654429\ \(0\)\
\-\ density\\:\\ 0\\.0500937810457014\ \(0\)\
\-\ image\\:\\ 0\\.04831348310305273\ \(0\)\
\-\ enhancing\\:\\ 0\\.04732412023140179\ \(0\)\
\-\ fat\\:\\ 0\\.04699333903165806\ \(0\)\
\-\ carcinoma\\:\\ 0\\.045187304355904026\ \(0\)\
\-\ shows\\:\\ 0\\.04433808515589255\ \(0\)\
\-\ blood\\:\\ 0\\.0438733609171631\ \(0\)\
\-\ axial\\:\\ 0\\.04363721887728354\ \(0\)\
\-\ due\\:\\ 0\\.04342439311318874\ \(0\)\
\-\ cell\\:\\ 0\\.04321493353427901\ \(0\)\
\-\ increased\\:\\ 0\\.04085087246459038\ \(0\)\
\-\ woman\\:\\ 0\\.03934382170439226\ \(0\)\
\-\ it\\:\\ 0\\.038670172792375265\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03795273445623198\ \(0\)\
\-\ large\\:\\ 0\\.03785154365369589\ \(0\)\
\-\ multiple\\:\\ 0\\.03695045825815961\ \(0\)\
\-\ contrast\\:\\ 0\\.03670552928762115\ \(0\)\
\-\ after\\:\\ 0\\.03664787450849115\ \(0\)\
\-\ lesion\\:\\ 0\\.036217713008429867\ \(0\)\
\-\ images\\:\\ 0\\.03494435994729255\ \(0\)\
\-\ has\\:\\ 0\\.034506525630186136\ \(0\)\
\-\ and\\:\\ 0\\.031220691361452398\ \(0\)\
\-\ as\\:\\ 0\\.030348906060160687\ \(0\)\
\-\ there\\:\\ 0\\.03005892141368758\ \(0\)\
\-\ ct\\:\\ 0\\.028760499765922758\ \(0\)\
\-\ pain\\:\\ 0\\.027032601619721156\ \(0\)\
\-\ patient\\:\\ 0\\.024570832869383163\ \(0\)\
